Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Revenue (2016 - 2025)

Orthofix Medical's Revenue history spans 16 years, with the latest figure at $219.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 34.13% year-over-year to $219.9 million, compared with a TTM value of $810.6 million through Dec 2025, up 12.27%, and an annual FY2025 reading of $822.3 million, up 9.97% over the prior year.
  • Revenue for Q4 2025 was $219.9 million at Orthofix Medical, up from $205.6 million in the prior quarter.
  • The five-year high for Revenue was $219.9 million in Q4 2025, with the low at $70.1 million in Q4 2021.
  • Average Revenue over 5 years is $154.8 million, with a median of $167.3 million recorded in 2023.
  • Biggest YoY gain for Revenue was 94.43% in 2021; the steepest drop was 55.15% in 2021.
  • Tracing OFIX's Revenue over 5 years: stood at $70.1 million in 2021, then soared by 74.27% to $122.2 million in 2022, then skyrocketed by 63.97% to $200.4 million in 2023, then dropped by 18.2% to $163.9 million in 2024, then surged by 34.13% to $219.9 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Revenue are $219.9 million (Q4 2025), $205.6 million (Q3 2025), and $191.4 million (Q2 2025).